Invention Grant
- Patent Title: Iontophoretic contact lens
-
Application No.: US15004867Application Date: 2016-01-22
-
Publication No.: US09937074B2Publication Date: 2018-04-10
- Inventor: Michael Manzo
- Applicant: Eyegate Pharmaceuticals, Inc.
- Applicant Address: US MA Waltham
- Assignee: EyeGate Pharmaceuticals, Inc.
- Current Assignee: EyeGate Pharmaceuticals, Inc.
- Current Assignee Address: US MA Waltham
- Agency: Burns & Levinson, LLP
- Agent Joseph M. Maraia
- Main IPC: A61N1/30
- IPC: A61N1/30 ; A61F9/00 ; G02C7/04 ; A61K9/00 ; A61N1/04

Abstract:
Contact lenses are provided for ocular iontophoretic therapy. Implementations include a reservoir adapted to contain a charged therapeutic compound, a current source providing iontophoretic current to the charged therapeutic composition to affect delivery of the charged therapeutic composition into an eyeball, and a sensing circuit controlling the current source to maintain a selected pH range of the charged therapeutic composition. Alternate embodiments include active, sacrificial electrodes for generating ions sufficient to provide electromotive repulsive force to the charged compound to effect transport into ocular tissue.
Public/Granted literature
- US20160213514A1 IONTOPHORETIC CONTACT LENS Public/Granted day:2016-07-28
Information query